Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab
Stanley C. Jordan, Klaus Kucher, Morten Bagger, Hans Hockey, Kristina Wagner, Noriko Ammerman, Ashley Vo
Topics & Concepts
MedicineAntibodyMonoclonal antibodyImmunologyImmunoglobulin GMonoclonalPharmacologyComplement system in diseasesSystemic Lupus Erythematosus ResearchPeripheral Neuropathies and Disorders